Recombinant Human SFRS3 Protein，GST

SFRS3 (serine/arginine-rich splicing factor 3) is a member of the serine/arginine-rich splicing factor family, which plays a crucial role in mRNA splicing, post-transcriptional regulation, and gene expression. The protein is involved in the processing of pre-mRNA, influencing alternative splicing events that ultimately determine the maturation and stability of mRNA transcripts. Dysregulation of SFRS3 has been implicated in various diseases, including cancer, where alterations in splicing patterns can contribute to tumorigenesis and the progression of malignancies. Recent studies have highlighted the significance of SFRS3 in specific cellular contexts, particularly in the regulation of splicing events related to oncogenes and tumor suppressor genes. Research into SFRS3 has also revealed its potential as a therapeutic target, as modulating its activity could restore normal splicing patterns and counteract the aberrant gene expression associated with diseases. Understanding the structural and functional aspects of SFRS3, including its interactions with other splicing factors and RNA substrates, is essential for elucidating its precise role in cellular processes and the molecular mechanisms underlying its involvement in various pathologies. Current studies are focused on characterizing SFRS3 through methods such as recombinant protein expression, functional assays, and interaction studies, aiming to provide insights into its role in splicing regulation and its potential as a biomarker or therapeutic target in oncology.